75
Participants
Start Date
February 28, 2024
Primary Completion Date
August 15, 2024
Study Completion Date
August 15, 2024
Pregabalin 75mg
Group A (pregabalin group) received oral pregabalin treatment administered at 150 mg daily, with 75 mg given every 12 hours.
An epidural blood patch (EBP)
Group B (EBP group) received active therapy in the form of an EBP
conservative treatment.
Group C (control group) received conservative treatment providing recommendations to the patients, including 24 hours of bed rest, stool softener, and consuming a minimum of 2.0 liters of fluid daily. Analgesics were permitted for pain relief depending on the patient's disease status.
Neveen Kohaf, Tanta
Benha University
OTHER
Al-Azhar University
OTHER